Term ends May 24, 2041 · Low confidence
20-year base term ends Mar 31, 2041
Held by Avalo Therapeutics, Inc.
Filed Jun 5, 2023 as application 18/329,069 · Granted Jun 17, 2025
Base term plus 54 days of patent term adjustment (USPTO delay)
Today
2021
2041
Clock starts
Mar 31, 2021
Mar 31, 2021
Term ends
May 24, 2041
May 24, 2041
Granted
Jun 17, 2025
Jun 17, 2025
base term
patent term adjustment
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
54
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,708,406, to May 24, 2041. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 54 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 31, 2021, when application 17/218,449, the earliest non-provisional in its chain, was filed (this one was filed Jun 5, 2023); a parent in its chain could not be resolved (the next row) | Mar 31, 2041 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +54 days, USPTO patent term adjustment record | May 24, 2041 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,708,406) | resolves to May 24, 2041, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 17218449 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | May 24, 2041 | Low confidence |
This family
| US 11,708,406 | In force May 2041 | May 2041 |
| US 12,331,107 | this patent May 2041 | May 2041 |
| Application 19/203,608 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 28, 2023 Reel 64090, frame 856 | Neil, Garry A.; Zafir-lavie, Inbal | Aevi Genomic Medicine, LLC | Assignment of Assignor's Interest |
| Jun 28, 2023 Reel 64090, frame 863 | Aevi Genomic Medicine, LLC; Avalo Therapeutics, Inc. | Avalo Therapeutics, Inc. | Merger and Change of Name |
| Sep 14, 2023 Reel 64900, frame 136 | Avalo Therapeutics, Inc. | Horizon Technology Finance Corporation | Security Interest |
| Nov 10, 2023 Reel 65547, frame 895 | Horizon Technology Finance Corporation | Avalo Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2041
Term ends May 24, 2041. Maintenance fees still fall due before then
Note
The 54 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 11,708,406, ends no earlier than this term, so it caps nothing.
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.